Skip to content 
At the intersection of Xinghuo North Road and Huasheng Road, a brand-new park is “growing” – this is the Gaoxin Science Valley – Biomedical Industrial Park, which is also a brand-new carrier of the New District Biomedical Valley. Between the buildings, delivery vehicles and construction vehicles are constantly coming and going, bustling with activity.
The park is being developed in three phases. The four buildings currently under construction are part of our first phase. The project’s project manager explained that the first phase was fully occupied before it was completed and handed over, and within less than half a year of its operation, the enterprise occupancy rate exceeded 90%. The second phase, which is currently under construction, also has a number of enterprises that have reserved spaces and are waiting to move in.
Invest 30 million yuan to build an energy station independently
Delivery means full signing. The second phase has been pre-registered. Why does this park have such “attractiveness”? Professionalism is the answer given by many established enterprises.
As one of the major projects of the city， Hi-Cheemu Bio-Pharmaceutical Industrial Park covers an area of 93 acres and has a total construction area of approximately 170,000 square meters. When the project was planned, it was positioned as a specialized industrial park for biomedicine， “tailored” for innovative pharmaceutical and medical device enterprises.
For example, in terms of the layout of the building structure, the floor height, load-bearing capacity, and column spacing of the park were all designed in accordance with the production characteristics of the industries. Not only were sufficient air duct shafts and exhaust pipelines reserved inside the building, but also a large, square and continuous space was left for enterprises, facilitating the layout of production lines.
In terms of the infrastructure of the park, there are even more remarkable features. Considering that the production environment of biopharmaceutical enterprises requires a constant temperature and humidity, the construction of the factory buildings involved a considerable investment in self-built energy facilities. Therefore, the park invested 30 million yuan to build a centralized energy center. It is said that this energy center is like a huge “central air conditioning system”, which can uniformly supply cold and heat sources to the entire park. Enterprises do not need to purchase external units, and it also saves the space for placing equipment.
Take a 5,000-square-meter factory as an example. If an enterprise builds its own energy facilities, the initial investment will be nearly 3 million yuan. With our system, this cost can be saved across the province. The project manager of the park calculated, “Many enterprise managers’ eyes light up as soon as they hear that there is an energy center here.”
Such professionalism has become the key to attracting enterprises. In addition, the park also has many supporting facilities such as industrial steam and dual-loop power supply, which can help enterprises reduce costs and increase efficiency.
“Landlords” can also become “shareholders”
If professional platforms are the reason that attracts enterprises to “come in”, then the transformation of the park into an “industrial partner” and the construction of an innovative ecosystem are the key factors that make more enterprises feel at ease to “stay on”.
Recently, Pu Guang Bio, which has set up its headquarters base in Building 1 of the park, has received another round of financing of several million yuan in Pre-B round. One of the investors is High Core Valley – Biomedical Park – the park has invested 1.5 million yuan in one go for this enterprise.
“It can be said that we have transformed from ‘landlords’ to ‘shareholders’.” The project manager of the park chuckled, explaining that the change in identity was a result of thinking about the relationship between the park and the enterprises.
As a specialized, innovative and high-quality enterprise in the field of in vitro diagnostics, Pu Guang Biotechnology plans to go public within three to four years. “What the enterprise needs is not just a headquarters space, but also a strategic partner that can accompany it throughout its growth and participate in its development.” In the opinion of this manager, only by truly becoming a partner of the enterprise can one stimulate its innovative potential and help it overcome one growth cycle after another.
This investment was not accidental. Earlier, the park established an investment promotion center to explore the “recruitment and investment linkage” model. The park also jointly formed an industrial investment fund of 50 million yuan with Nanjing Bank, Jiangbei Construction Investment, and Bangsheng Capital.
It is known that this fund mainly invests in high-quality enterprises within and to be established in the park. It can better meet the financing needs of growth-stage enterprises and also becomes a powerful tool for attracting investment.
Professional platforms and companionship during growth have made the story of “delivery equals full signing” possible.
Now, looking around the park, Building 1 is the headquarters base of Pu Guang Biotechnology; Building 4 has been occupied by the star enterprise Yao Tang Biotechnology for gene editing therapy; in Building 5, enterprises such as Ting Sheng Technology, Anbiao Testing, and Guxi Biotechnology have gathered here; and Building 6 has welcomed a number of innovative teams from all over, including Letousi. The clustering of enterprises has brought about a wonderful “chemical reaction”, and an active industrial chain has quietly taken shape.
The first phase is “fully staffed”, and the second and third phases have also been successively advanced. It is reported that the second phase of the park is in full swing of construction and is expected to be delivered by the end of this year; the third phase is also planned to start construction in the second half of this year, bringing more innovative forces to the life health industry of the new district.
